Power Law company profile

Pharvaris

Biotech & Life Sciences · Leiden, Netherlands · Founded 2015 · IPO 2021 Unicorn

Bringing an oral bradykinin b2 receptor antagonist to patients

Valuation

$1.69B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

11 investors on Pharvaris's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

EQT Life Sciences

Kurma Partners

Series B+ 9 investors entered at this stage

General Atlantic

Eurazeo

Venrock

Bain Capital Life Sciences

Foresite Capital

Bain Capital

Cormorant Asset Management

Viking Global Investors

venBio Partners

Global footprint

Where Pharvaris has talent and traffic

Workforce by country

9 countries with
team presence

🇺🇸 United States38.6%

🇨🇭 Switzerland34.3%

🇳🇱 Netherlands21.6%

🇩🇰 Denmark1.1%

🇩🇪 Germany1.1%

Top 5 of 9 shown

Web traffic by country

5.9K monthly visits
across markets

🇺🇸 United States64.4%

🇮🇳 India15.3%

🇨🇭 Switzerland8.5%

🇳🇱 Netherlands6.8%

🇫🇷 France3.4%

Top 5 markets shown

Patent intelligence

$15M patent portfolio · 21 active families

Estimated portfolio value

$15M

0.88% of market cap · 52.3× smaller than top peer BioNTech ($780M)

21 active patent families

Where Pharvaris innovates Bradykinin Receptor AntagonistsBradykininReceptor antagonistAcetamideBradykinin B2 Receptor Antagonists

Where Pharvaris concentrates vs peers

Each axis is a top-10 topic across Pharvaris and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Pharvaris

An AI-synthesized read of the highest-engagement posts about Pharvaris on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pharvaris on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles